diphenyliodonium has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernaeus, S; Hälldin, J; Land, T; Pettersson, C; Reis, K | 1 |
| Balbis, E; Cottalasso, D; De Ciucis, C; Domenicotti, C; Marengo, B; Marinari, UM; Patriarca, S; Pistoia, V; Pronzato, MA; Raffaghello, L; Traverso, N; Verzola, D | 1 |
2 other study(ies) available for diphenyliodonium and Neuroblastoma
| Article | Year |
|---|---|
NADPH oxidase inhibitor diphenyliodonium abolishes lipopolysaccharide-induced down-regulation of transferrin receptor expression in N2a and BV-2 cells.
Topics: Animals; Anti-Infective Agents; Apoferritins; Biphenyl Compounds; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Lipopolysaccharides; Mice; Microglia; Neuroblastoma; Onium Compounds; Reactive Oxygen Species; Receptors, Transferrin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2006 |
Mechanisms of BSO (L-buthionine-S,R-sulfoximine)-induced cytotoxic effects in neuroblastoma.
Topics: Acetophenones; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Ascorbic Acid; Benzopyrans; Biphenyl Compounds; Buthionine Sulfoximine; Calpain; Caspases; Catalase; Cell Line, Tumor; DNA Damage; Glutathione; Humans; N-Myc Proto-Oncogene Protein; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Onium Compounds; Protein Kinase C; Reactive Oxygen Species; Superoxide Dismutase; Superoxide Dismutase-1 | 2008 |